Partnership will enable the identification of potential therapeutic candidates for autoimmune diseases in Microba’s extensive strain bank.
We are innovating to help humanity achieve some of its most inspiring medical advancements in the 21st century. Read about Microba’s progress, partnership news and latest discoveries.
Leading Australian universities will explore the ‘cognobiome’ of soldiers using Microba’s analysis platform to discover opportunities for improving...
Published study found a method designed for preserving forensic DNA outperformed other commonly used faecal preservation methods.
Microba Community Profiler (MCP) outperforms existing profilers for accurate and comprehensive characterisation of the human gut microbiome.